Before the approval of Favipiravir , there were no mitigating medications for the disease except for supportive therapy .
Prior to the approval of Favipiravir there were no specific antivirals against this disease , and the resulting clinical manifestations and complications have been managed with supportive therapy .
Coronavirus disease 2019